;PMID: 11435722
;source_file_708.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..28] = [t:0..28]
;1)sentence:[e:33..121] = [t:33..121]
;2)section:[e:125..175] = [t:125..175]
;3)section:[e:179..293] = [t:179..293]
;4)sentence:[e:297..308] = [t:297..308]
;5)sentence:[e:309..442] = [t:309..442]
;6)sentence:[e:443..613] = [t:443..613]
;7)sentence:[e:615..623] = [t:615..623]
;8)sentence:[e:624..938] = [t:624..938]
;9)sentence:[e:939..947] = [t:939..947]
;10)sentence:[e:948..1132] = [t:948..1132]
;11)sentence:[e:1133..1144] = [t:1133..1144]
;12)sentence:[e:1145..1294] = [t:1145..1294]
;13)section:[e:1298..1343] = [t:1298..1343]

;section 0 Span:0..28
;Digestion  2001;63(4):229-33
(SEC
  (FRAG (NNP:[0..9] Digestion) (CD:[11..19] 2001;63-LRB-) (CD:[19..21] 4-RRB-)
        (CD:[21..25] :229) (::[25..26] -) (CD:[26..28] 33)))

;sentence 1 Span:33..121
;K-ras and p53 mutations in colonic lavage fluid of patients with colorectal 
;neoplasias.
;[33..38]:gene-rna:"K-ras"
;[43..46]:gene-rna:"p53"
;[98..120]:malignancy:"colorectal  neoplasias"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[33..38] K-ras)
        (NML-1 (-NONE-:[38..38] *P*)))
      (CC:[39..42] and)
      (NP (NN:[43..46] p53)
        (NML-1 (NNS:[47..56] mutations))))
    (PP-LOC (IN:[57..59] in)
      (NP
        (NP (JJ:[60..67] colonic) (NN:[68..74] lavage) (NN:[75..80] fluid))
        (PP (IN:[81..83] of)
          (NP
            (NP (NNS:[84..92] patients))
            (PP (IN:[93..97] with)
              (NP (JJ:[98..108] colorectal) (NNS:[110..120] neoplasias)))))))
    (.:[120..121] .)))

;section 2 Span:125..175
;Heinzlmann M, Neynaber S, Heldwein W, Folwaczny C.
(SEC
  (FRAG (NNP:[125..135] Heinzlmann) (NNP:[136..138] M,)
        (NNP:[139..147] Neynaber) (NNP:[148..150] S,) (NNP:[151..159] Heldwein)
        (NNP:[160..161] W) (,:[161..162] ,) (NNP:[163..172] Folwaczny)
        (NNP:[173..175] C.)))

;section 3 Span:179..293
;Department of Gastroenterology, Medizinische Klinik Innenstadt, 
;Ludwig-Maximilians-Universitat, Munchen, Germany.
(SEC
  (FRAG (NNP:[179..189] Department) (IN:[190..192] of)
        (NNP:[193..209] Gastroenterology) (,:[209..210] ,)
        (NNP:[211..223] Medizinische) (NNP:[224..230] Klinik)
        (NNP:[231..241] Innenstadt) (,:[241..242] ,) (NNP:[244..250] Ludwig)
        (::[250..251] -) (NNP:[251..262] Maximilians) (::[262..263] -)
        (NNP:[263..274] Universitat) (,:[274..275] ,) (NNP:[276..283] Munchen)
        (,:[283..284] ,) (NNP:[285..292] Germany) (.:[292..293] .)))

;sentence 4 Span:297..308
;BACKGROUND:
(SENT
  (NP (NN:[297..307] BACKGROUND) (::[307..308] :)))

;sentence 5 Span:309..442
;The adenoma-carcinoma sequence has its molecular basis in several  gene
;mutations of which K-ras and p53 are of paramount importance.
;[313..320]:malignancy:"adenoma"
;[321..330]:malignancy:"carcinoma"
;[400..405]:gene-rna:"K-ras"
;[410..413]:gene-rna:"p53"
(SENT
  (S
    (NP-SBJ (DT:[309..312] The)
      (NML
        (NML (NN:[313..320] adenoma))
        (PP (HYPH:[320..321] -)
          (NP (NN:[321..330] carcinoma))))
      (NN:[331..339] sequence))
    (VP (VBZ:[340..343] has)
      (NP
        (NP (PRP$:[344..347] its) (JJ:[348..357] molecular)
            (NN:[358..363] basis))
        (PP (IN:[364..366] in)
          (NP
            (NP (JJ:[367..374] several) (NN:[376..380] gene)
                (NNS:[381..390] mutations))
            (SBAR
              (WHPP-1 (IN:[391..393] of)
                (WHNP (WDT:[394..399] which)))
              (S
                (NP-SBJ (NN:[400..405] K-ras) (CC:[406..409] and)
                        (NN:[410..413] p53))
                (VP (VBP:[414..417] are)
                  (PP-PRD-1 (-NONE-:[417..417] *T*))
                  (PP (IN:[418..420] of)
                    (NP (JJ:[421..430] paramount) (NN:[431..441] importance))))))))))
    (.:[441..442] .)))

;sentence 6 Span:443..613
;The aims of  this study were to evaluate whether these genetic alterations
;can be detected in  colonic lavage fluid from patients with colorectal
;adenomas and carcinomas.
;[578..597]:malignancy:"colorectal adenomas"
;[602..612]:malignancy:"carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[443..446] The) (NNS:[447..451] aims))
      (PP (IN:[452..454] of)
        (NP (DT:[456..460] this) (NN:[461..466] study))))
    (VP (VBD:[467..471] were)
      (S-PRP-PRD
        (NP-SBJ (-NONE-:[471..471] *))
        (VP (TO:[472..474] to)
          (VP (VB:[475..483] evaluate)
            (SBAR (IN:[484..491] whether)
              (S
                (NP-SBJ-2 (DT:[492..497] these) (JJ:[498..505] genetic)
                          (NNS:[506..517] alterations))
                (VP (MD:[518..521] can)
                  (VP (VB:[522..524] be)
                    (VP (VBN:[525..533] detected)
                      (NP-2 (-NONE-:[533..533] *))
                      (PP-LOC (IN:[534..536] in)
                        (NP
                          (NP (JJ:[538..545] colonic) (NN:[546..552] lavage)
                              (NN:[553..558] fluid))
                          (PP (IN:[559..563] from)
                            (NP
                              (NP (NNS:[564..572] patients))
                              (PP (IN:[573..577] with)
                                (NP
                                  (NP
                                    (ADJP-1 (JJ:[578..588] colorectal))
                                    (NNS:[589..597] adenomas))
                                  (CC:[598..601] and)
                                  (NP
                                    (ADJP-1 (-NONE-:[601..601] *P*))
                                    (NNS:[602..612] carcinomas)))))))))))))))))
    (.:[612..613] .)))

;sentence 7 Span:615..623
;METHODS:
(SENT
  (NP (NNS:[615..622] METHODS) (::[622..623] :)))

;sentence 8 Span:624..938
;In 45 patients with adenomas, 20 patients with colorectal carcinomas  and 38
;patients with non-neoplastic and noninflammatory diseases of the colon  p53
;and K-ras mutations were evaluated in colonic lavage fluid employing 
;single-strand confirmation polymorphism analysis and dot-blot hybridization, 
;respectively.
;[644..652]:malignancy:"adenomas"
;[671..692]:malignancy:"colorectal carcinomas"
;[773..776]:gene-rna:"p53"
;[781..786]:gene-rna:"K-ras"
(SENT
  (S
    (PP (IN:[624..626] In)
      (NP
        (NP
          (NP (CD:[627..629] 45) (NNS:[630..638] patients))
          (PP (IN:[639..643] with)
            (NP (NNS:[644..652] adenomas))))
        (,:[652..653] ,)
        (NP
          (NP (CD:[654..656] 20) (NNS:[657..665] patients))
          (PP (IN:[666..670] with)
            (NP (JJ:[671..681] colorectal) (NNS:[682..692] carcinomas))))
        (CC:[694..697] and)
        (NP
          (NP (CD:[698..700] 38) (NNS:[701..709] patients))
          (PP (IN:[710..714] with)
            (NP
              (NP
                (NP (AFX:[715..718] non) (HYPH:[718..719] -)
                    (JJ:[719..729] neoplastic)
                  (NML-2 (-NONE-:[729..729] *P*)))
                (CC:[730..733] and)
                (NP (JJ:[734..749] noninflammatory)
                  (NML-2 (NNS:[750..758] diseases))))
              (PP (IN:[759..761] of)
                (NP (DT:[762..765] the) (NN:[766..771] colon))))))))
    (NP-SBJ-3
      (NML (NN:[773..776] p53)
        (NML-1 (-NONE-:[776..776] *P*)))
      (CC:[777..780] and)
      (NML (NN:[781..786] K-ras)
        (NML-1 (NNS:[787..796] mutations))))
    (VP (VBD:[797..801] were)
      (VP (VBN:[802..811] evaluated)
        (NP-3 (-NONE-:[811..811] *))
        (PP-LOC (IN:[812..814] in)
          (NP (JJ:[815..822] colonic) (NN:[823..829] lavage)
              (NN:[830..835] fluid)))
        (S-ADV
          (NP-SBJ (-NONE-:[835..835] *))
          (VP (VBG:[836..845] employing)
            (NP
              (NP
                (NML
                  (NML (JJ:[847..853] single) (HYPH:[853..854] -)
                       (NN:[854..860] strand))
                  (NN:[861..873] confirmation) (NN:[874..886] polymorphism))
                (NN:[887..895] analysis))
              (CC:[896..899] and)
              (NP
                (NML (NN:[900..903] dot) (HYPH:[903..904] -)
                     (NN:[904..908] blot))
                (NN:[909..922] hybridization)))))
        (,:[922..923] ,)
        (ADVP (RB:[925..937] respectively))))
    (.:[937..938] .)))

;sentence 9 Span:939..947
;RESULTS:
(SENT
  (NP (NNS:[939..946] RESULTS) (::[946..947] :)))

;sentence 10 Span:948..1132
;Mutations of the K-ras and the p53 gene were found in  15.6% (p = 0.065) of
;patients with adenomas, in 25.0 % (p = 0.016) of patients  with carcinomas
;and in 2.6% in the control group.
;[965..970]:gene-rna:"K-ras"
;[979..982]:gene-rna:"p53"
;[1038..1046]:malignancy:"adenomas"
;[1088..1098]:malignancy:"carcinomas"
(SENT
  (S
    (NP-SBJ-2
      (NP (NNS:[948..957] Mutations))
      (PP (IN:[958..960] of)
        (NP
          (NP (DT:[961..964] the) (NN:[965..970] K-ras)
            (NML-1 (-NONE-:[970..970] *P*)))
          (CC:[971..974] and)
          (NP (DT:[975..978] the) (NN:[979..982] p53)
            (NML-1 (NN:[983..987] gene))))))
    (VP (VBD:[988..992] were)
      (VP (VBN:[993..998] found)
        (NP-2 (-NONE-:[998..998] *))
        (PP-LOC
          (PP (IN:[999..1001] in)
            (NP
              (NP (CD:[1003..1007] 15.6) (NN:[1007..1008] %)
                (PRN (-LRB-:[1009..1010] -LRB-)
                  (S
                    (NP-SBJ (NN:[1010..1011] p))
                    (VP (SYM:[1012..1013] =)
                      (NP (CD:[1014..1019] 0.065))))
                  (-RRB-:[1019..1020] -RRB-)))
              (PP (IN:[1021..1023] of)
                (NP
                  (NP (NNS:[1024..1032] patients))
                  (PP (IN:[1033..1037] with)
                    (NP (NNS:[1038..1046] adenomas)))))))
          (,:[1046..1047] ,)
          (PP (IN:[1048..1050] in)
            (NP
              (NP (CD:[1051..1055] 25.0) (NN:[1056..1057] %)
                (PRN (-LRB-:[1058..1059] -LRB-)
                  (S
                    (NP-SBJ (NN:[1059..1060] p))
                    (VP (SYM:[1061..1062] =)
                      (NP (CD:[1063..1068] 0.016))))
                  (-RRB-:[1068..1069] -RRB-)))
              (PP (IN:[1070..1072] of)
                (NP
                  (NP (NNS:[1073..1081] patients))
                  (PP (IN:[1083..1087] with)
                    (NP (NNS:[1088..1098] carcinomas)))))))
          (CC:[1099..1102] and)
          (PP (IN:[1103..1105] in)
            (NP
              (NP (CD:[1106..1109] 2.6) (NN:[1109..1110] %))
              (PP (IN:[1111..1113] in)
                (NP (DT:[1114..1117] the) (NN:[1118..1125] control)
                    (NN:[1126..1131] group))))))))
    (.:[1131..1132] .)))

;sentence 11 Span:1133..1144
;CONCLUSION:
(SENT
  (NP (NN:[1133..1143] CONCLUSION) (::[1143..1144] :)))

;sentence 12 Span:1145..1294
;Genetic  alterations in the colonic lavage fluid could be an additional
;diagnostic tool  for the surveillance of patients with colorectal
;neoplasias.
;[1272..1293]:malignancy:"colorectal neoplasias"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[1145..1152] Genetic) (NNS:[1154..1165] alterations))
      (PP-LOC (IN:[1166..1168] in)
        (NP (DT:[1169..1172] the) (JJ:[1173..1180] colonic)
            (NN:[1181..1187] lavage) (NN:[1188..1193] fluid))))
    (VP (MD:[1194..1199] could)
      (VP (VB:[1200..1202] be)
        (NP-PRD
          (NP (DT:[1203..1205] an) (JJ:[1206..1216] additional)
              (JJ:[1217..1227] diagnostic) (NN:[1228..1232] tool))
          (PP (IN:[1234..1237] for)
            (NP
              (NP (DT:[1238..1241] the) (NN:[1242..1254] surveillance))
              (PP (IN:[1255..1257] of)
                (NP
                  (NP (NNS:[1258..1266] patients))
                  (PP (IN:[1267..1271] with)
                    (NP (JJ:[1272..1282] colorectal)
                        (NNS:[1283..1293] neoplasias))))))))))
    (.:[1293..1294] .)))

;section 13 Span:1298..1343
;PMID: 11435722 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1298..1302] PMID) (::[1302..1303] :) (CD:[1304..1312] 11435722)
        (NN:[1313..1314] -LSB-) (NNP:[1314..1320] PubMed) (::[1321..1322] -)
        (NN:[1323..1330] indexed) (IN:[1331..1334] for)
        (NNP:[1335..1343] MEDLINE-RSB-)))
